Video Experimental Relacionado
Updated: Jul 16, 2026
07:34
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
La comercialización por Internet de productos a base de hierbas
Charles A Morris1, Jerry Avorn
1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02120, USA. camorris@partners.org
JAMA
|September 18, 2003
Resumen
Las afirmaciones en línea sobre suplementos a base de hierbas a menudo engañan a los consumidores, ya que muchos sitios hacen afirmaciones relacionadas con enfermedades sin las descargas de responsabilidad adecuadas. Se necesita una regulación más estricta para estos populares suplementos dietéticos.
Área de la Ciencia:
- Medicina a base de hierbas e información de salud del consumidor.
- El panorama regulatorio de los suplementos dietéticos.
Sus antecedentes:
- La Ley de Educación y Salud de los Suplementos Dietéticos de 1994 limitó la supervisión de la FDA de los suplementos dietéticos.
- Internet es una fuente primaria para los consumidores que buscan información sobre terapias a base de hierbas.
Objetivo del estudio:
- Evaluar la información y las declaraciones de propiedades saludables presentadas en línea para los 8 productos a base de hierbas más vendidos.
- Evaluar el cumplimiento de las directrices reglamentarias con respecto a las declaraciones de propiedades saludables y exenciones de responsabilidad.
Principales métodos:
- Buscado en 5 motores de búsqueda principales para 8 suplementos de hierbas populares (por ejemplo, ginkgo biloba, hierba de San Juan).
- Analizó el contenido de salud en la primera página de los resultados de búsqueda de 443 sitios web calificados en inglés.
- Tipo de sitio web registrado, enlaces patrocinados, referencias, indicaciones, reclamos y exenciones de responsabilidad, categorizando los reclamos según los criterios de la FDA.
Principales resultados:
- El 76% de los sitios web analizados estaban orientados al comercio minorista.
- El 81% de los sitios minoristas hicieron declaraciones de salud, con el 55% afirmando tratar o curar enfermedades específicas.
- El 52% de los sitios con afirmaciones de salud omitió las exenciones de responsabilidad federales; solo el 12% proporcionó información referenciada sin enlaces al proveedor.
Conclusiones:
- Los consumidores pueden ser engañados por afirmaciones sin fundamento relacionadas con enfermedades para productos a base de hierbas en línea.
- Los médicos deben ser conscientes de la prevalencia de esta información fácilmente accesible y potencialmente engañosa.
- Es necesaria una regulación reforzada para garantizar que los productos a base de hierbas cumplan con estándares basados en la evidencia comparables con otros medicamentos.
Videos de Conceptos Relacionados
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.